Pharmacists in Atoka, OK Accepting Medicare
9 Pharmacists found. Showing 1 - 9
 Donald Ritter, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 744 S Mississippi Ave Ste A, Atoka, OK 74525 Phone: 580-889-0230 Fax: 580-889-3060 |
 Megan Beall, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1983 S Mississippi Ave, Atoka, OK 74525 Phone: 580-889-3000 |
David Jason Lanig, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 872 W 13th St, Atoka, OK 74525 Phone: 580-889-3331 Fax: 580-889-7765 |
Susan Ritter, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 744 S Mississippi Ave, Atoka, OK 74525 Phone: 580-889-1283 |
Jason Chappell, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 702 S Mississippi Ave, Atoka, OK 74525 Phone: 580-889-3353 |
Dr. Robert Lynn Frederick, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1002 W 13th St, Atoka, OK 74525 Phone: 580-889-3331 Fax: 580-889-7765 |
Ryan Jay Ritter, D.PH. (PHARMACIST) Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 702 S Mississippi Ave, Atoka, OK 74525 Phone: 580-889-3353 Fax: 580-889-3060 |
Ryan Butler, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1983 S Mississippi Ave, Atoka, OK 74525 Phone: 580-889-3000 |
Sara Marie Jezierski, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1983 S Mississippi Ave, Atoka, OK 74525 Phone: 580-889-3000 Fax: 580-889-8822 |
News Archive
Hearing impairment risk high with diabetes
People with diabetes are at high risk for developing a hearing impairment, report researchers.
Nabi Biopharmaceuticals, Diosynth sign long-term commercial manufacturing agreement
Nabi Biopharmaceuticals announced today that it has entered into a long-term commercial manufacturing agreement with Diosynth RTP, Inc. for the manufacture of Drug Substance integral to the production of NicVAX, Nabi's innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse.
Senomyx prices common stock offering at $2.80 per share
Senomyx, Inc. announced today the pricing of an underwritten public offering of 7,142,857 shares of its common stock at a price to the public of $2.80 per share. The gross proceeds from the sale of the shares, before underwriting discounts and commissions and other offering expenses, are expected to be approximately $20.0 million. The offering is expected to close on or about February 18, 2010, subject to customary closing conditions. Senomyx has also granted the underwriters a 30-day option to purchase up to an aggregate of 1,071,428 additional shares of common stock to cover over-allotments, if any.
Medical biller develops special ranking system for insurers
Jonathan Bush recognized that getting paid in health care is a problem, NPR's Planet Money blog reports: "Say the patient is covered by Blue Cross. Which Blue Cross? Did she need a referral? What's the right billing code?" So he left the birthing center business to get "into a different part of the health-care business: He launched athenahealth, a company that handles billing for doctors' offices."
Mice on Prozac may help improve serotonin-based antidepressants
Depressed mice, like depressed humans, often appear listless and antisocial , the result of aberrant levels of brain chemicals such as serotonin.
› Verified 7 days ago